Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Pasithea Therapeutics has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Pasithea Therapeutics's investors include Vivo Capital, Janus Henderson Investors, Adage Capital Management, Columbia Threadneedle Investments, Coastlands Capital.
Pasithea Therapeutics is headquartered in Miami Beach, United States.
Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.
Pasithea Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pasithea Therapeutics — Funding & Investors." VCBacked, November 28, 2025, https://www.vcbacked.co/company/pasithea-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Pasithea Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pasithea-therapeutics
{{cite web |title=Pasithea Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pasithea-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated